Progastrin and its Products from Patients with Chronic Viral Hepatitis and Liver Cirrhosis

Abstract

Plasma levels of progastrin and gastrin are significantly increased in cirrhotic patients and this could be attributed to reduced metabolism of these peptides in liver cirrhosis and to their increased release due to H. pylori infection rate in this disease.